Winthrop’s lung cancer specialists are intent on translating important understandings of bench side research into meaningful treatment advances that can be brought to the bedside. The Lung Cancer Program is fully committed to understanding the molecular origins of every cancer. In this context, all patients are screened with a full array of laboratory tests that may best define individualized treatments. What’s more, they collaborate with Cold Spring Harbor Laboratory scientists studying lung cancer.
Winthrop’s active cancer clinical trials program offers a broad array of options to patients with cancer, who have the opportunity to participate in cutting-edge research that promises to improve cure rates for many common malignancies.
Oncologists have access to National Cancer Institute-sponsored cooperative group trials through our Southwest Oncology Group affiliation, Gynecologic Oncology Group, and Children’s Oncology Group, as well as high priority research trials through the CTSU (Clinical Trials Support Unit). Patients are also entered into trials sponsored by pharmaceutical companies to test promising new anti-cancer therapies.
In addition, gynecologic oncologists, medical oncologists, pediatric oncologists, radiation oncologists and surgical oncologists originate cancer clinical trials evaluated by the Hospital’s human research Institutional Review Board, to ensure the utmost in safety and scientific rigor.
More information about Clinical Trials.